ARTICLE | Politics & Policy
Democratic reps want details on Sovaldi's cost
March 20, 2014 11:58 PM UTC
Democratic members of the U.S. House of Representatives Energy and Commerce Committee requested information on pricing methodology for HCV drug Sovaldi sofosbuvir from Gilead Sciences Inc. (NASDAQ:GILD). In a HCV NS5B polymerase inhibitor in December. ...